| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |